Travere Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TVTX research report →
About the company
Travere Therapeutics, Inc. , a biopharmaceutical firm headquartered in San Diego, California, was founded in 2008 with a mission to discover, develop, commercialize, and deliver treatments for rare diseases. The company adopted its current name in November 2020, previously operating as Retrophin, Inc.
- CEO
- Eric Dube
- IPO
- 2012
- Employees
- 385
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $5.29B
- P/E
- -116.16
- P/S
- 9.87
- P/B
- 52.97
- EV/EBITDA
- 143.82
- Div Yield
- 0.00%
- Gross Margin
- 93.95%
- Op Margin
- -10.64%
- Net Margin
- -4.00%
- ROE
- -26.79%
- ROIC
- -13.09%
- Revenue
- $490.73M · 110.45%
- Net Income
- $-25,546,000 · 92.06%
- EPS
- $-0.56 · 86.27%
- Op Income
- $-62,824,000
- FCF YoY
- 93.98%
- 52W High
- $60.10
- 52W Low
- $14.44
- 50D MA
- $47.43
- 200D MA
- $35.17
- Beta
- 1.11
- Avg Volume
- 2.56M
Get TickerSpark's AI analysis on TVTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 22, 26 | Inrig Jula | other | 468 |
| Jun 12, 26 | Coughlin Timothy | other | 10,000 |
| Jun 12, 26 | Coughlin Timothy | sell | 10,000 |
| Jun 12, 26 | Coughlin Timothy | other | 10,000 |
| Jun 12, 26 | Baynes Roy D. | other | 4,500 |
| Jun 12, 26 | Baynes Roy D. | sell | 4,500 |
| Jun 12, 26 | Baynes Roy D. | other | 4,500 |
| May 19, 26 | Williams Brinkley Ruth | other | 4,000 |
| May 19, 26 | Williams Brinkley Ruth | other | 12,000 |
| May 19, 26 | Squarer Ron | other | 4,000 |
Our TVTX coverage
Recent articles, reports, and earnings notes.
No research on TVTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TVTX report →Similar companies
Peers in the same neighborhood.